• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KIAA1429 通过 SLC7A11 的 mA 依赖性转录后修饰来保护肝癌细胞免受铁死亡。

KIAA1429 protects hepatocellular carcinoma cells from ferroptotic cell death with a m A-dependent posttranscriptional modification of SLC7A11.

机构信息

Department of General Surgery, The Affiliated Bozhou Hospital of Anhui Medical University, Bozhou, Anhui, China.

Division of Life Sciences and Medicine, Department of Cancer Radiotherapy, The First Affiliated Hospital of USTC, University of Science and Technology of China (Anhui Provincial Cancer Hospital), Hefei, Anhui, China.

出版信息

J Cell Mol Med. 2023 Dec;27(24):4118-4132. doi: 10.1111/jcmm.17997. Epub 2023 Oct 13.

DOI:10.1111/jcmm.17997
PMID:37830241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10746954/
Abstract

N -methyladenosine (m A) modification represents the most abundant internal methylation of eukaryotic RNAs. KIAA1429 acts as a key component of the m A methyltransferase complex, but its function and mechanism in ferroptotic cell death of hepatocellular carcinoma (HCC) are barely defined. We found that KIAA1429 suppression triggered ferroptosis in HCC cells according to increased cell death, iron and MDA levels, C11-BODIPY-positive cells, ROS production and decreased GSH level. Ferroptosis inhibitors ferrostatin-1 (0.5 μM) and liproxstatin-1 (10 μM) blocked KIAA1429 suppression-induced ferroptosis of HCC cells. In addition, overexpressed KIAA1429 notably heightened the activity of cystine/glutamate antiporter (SLC7A11). SLC7A11 up-regulation partially hindered KIAA1429 inhibition-mediated ferroptosis of HCC cells. The regulation SLC7A11 by KIAA1429 was attenuated by global m A inhibitor cycloleucine (40 μM). RNA immunoprecipitation confirmed the binding of KIAA1429 to m A on SLC7A11 transcript. Additionally, it was proven that KIAA1429 inhibition mitigated HCC growth in subcutaneous xenograft mice through SLC7A11. Altogether, our findings first propose that KIAA1429 protects HCC cells from ferroptosis with a m A-dependent post-transcriptional modification of SLC7A11 and offer a novel insight into the dysregulated epi-transcriptomics in the context of HCC.

摘要

N6-甲基腺苷(m6A)修饰是真核 RNA 中最丰富的内部甲基化。KIAA1429 作为 m6A 甲基转移酶复合物的关键组成部分发挥作用,但它在肝癌(HCC)铁死亡细胞死亡中的功能和机制尚未明确。我们发现,根据细胞死亡增加、铁和 MDA 水平升高、C11-BODIPY 阳性细胞、ROS 产生减少和 GSH 水平降低,KIAA1429 抑制可触发 HCC 细胞发生铁死亡。铁死亡抑制剂 ferrostatin-1(0.5μM)和 liproxstatin-1(10μM)阻断了 KIAA1429 抑制诱导的 HCC 细胞铁死亡。此外,过表达的 KIAA1429 显著提高了胱氨酸/谷氨酸反向转运蛋白(SLC7A11)的活性。SLC7A11 的上调部分阻碍了 KIAA1429 抑制介导的 HCC 细胞铁死亡。由 KIAA1429 调节的 SLC7A11 被全局 m6A 抑制剂环亮氨酸(40μM)减弱。RNA 免疫沉淀证实 KIAA1429 与 SLC7A11 转录物上的 m6A 结合。此外,证明 KIAA1429 抑制通过 SLC7A11 减轻了皮下异种移植小鼠的 HCC 生长。总之,我们的研究结果首次提出 KIAA1429 通过 SLC7A11 的 m6A 依赖性转录后修饰来保护 HCC 细胞免受铁死亡,并为 HCC 背景下失调的 epi 转录组学提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/c57917a9783a/JCMM-27-4118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/c26c2161cbcc/JCMM-27-4118-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/15701b82df00/JCMM-27-4118-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/354ffad9d42a/JCMM-27-4118-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/d70c14bf34bd/JCMM-27-4118-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/6b7a53be7b5e/JCMM-27-4118-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/477b631e035f/JCMM-27-4118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/c57917a9783a/JCMM-27-4118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/c26c2161cbcc/JCMM-27-4118-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/15701b82df00/JCMM-27-4118-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/354ffad9d42a/JCMM-27-4118-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/d70c14bf34bd/JCMM-27-4118-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/6b7a53be7b5e/JCMM-27-4118-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/477b631e035f/JCMM-27-4118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de1c/10746954/c57917a9783a/JCMM-27-4118-g002.jpg

相似文献

1
KIAA1429 protects hepatocellular carcinoma cells from ferroptotic cell death with a m A-dependent posttranscriptional modification of SLC7A11.KIAA1429 通过 SLC7A11 的 mA 依赖性转录后修饰来保护肝癌细胞免受铁死亡。
J Cell Mol Med. 2023 Dec;27(24):4118-4132. doi: 10.1111/jcmm.17997. Epub 2023 Oct 13.
2
Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11.缺氧通过抑制 METTL14 触发的 YTHDF2 依赖性 SLC7A11 沉默来阻断肝细胞癌的铁死亡。
J Cell Mol Med. 2021 Nov;25(21):10197-10212. doi: 10.1111/jcmm.16957. Epub 2021 Oct 5.
3
ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis.转录激活因子 4 通过诱导 SLC7A11(xCT)抑制应激相关的铁死亡来抑制肝癌发生。
J Hepatol. 2023 Aug;79(2):362-377. doi: 10.1016/j.jhep.2023.03.016. Epub 2023 Mar 28.
4
SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.SHP-1/STAT3 信号轴调控 BECN1 和 SLC7A11 之间的偶联促进索拉非尼诱导的肝细胞癌铁死亡。
Int J Mol Sci. 2022 Sep 21;23(19):11092. doi: 10.3390/ijms231911092.
5
Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation.长链非编码 RNA DUXAP8 的缺失协同增强索拉非尼诱导的肝细胞癌中铁死亡通过 SLC7A11 的去棕榈酰化作用。
Clin Transl Med. 2023 Jun;13(6):e1300. doi: 10.1002/ctm2.1300.
6
Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma.外泌体来源的 circUPF2 通过重新分配肝细胞癌中的铁死亡敏感性来增强对靶向治疗的抵抗力。
J Nanobiotechnology. 2024 May 30;22(1):298. doi: 10.1186/s12951-024-02582-6.
7
The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.N6-甲基腺苷修饰通过抑制肝母细胞瘤中 SLC7A11 mRNA 的去腺苷酸化增强铁死亡抵抗。
Clin Transl Med. 2022 May;12(5):e778. doi: 10.1002/ctm2.778.
8
KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.KIAA1429 通过 GATA3 的 N6-甲基腺苷依赖性转录后修饰促进肝癌进展。
Mol Cancer. 2019 Dec 19;18(1):186. doi: 10.1186/s12943-019-1106-z.
9
AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP/SLC7A11 signaling pathway.AKR1C3 通过调控 YAP/SLC7A11 信号通路抑制肝癌细胞中的铁死亡。
Mol Carcinog. 2023 Jun;62(6):833-844. doi: 10.1002/mc.23527. Epub 2023 Mar 15.
10
RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA.RNA 结合蛋白 DAZAP1 通过与 SLC7A11 mRNA 相互作用促进 HCC 进展并调节铁死亡。
Exp Cell Res. 2021 Feb 1;399(1):112453. doi: 10.1016/j.yexcr.2020.112453. Epub 2020 Dec 29.

引用本文的文献

1
The Multifaceted Role of VIRMA, a Core Component of the Methyltransferase Complex, in Cancer and Cancer Therapy.VIRMA(甲基转移酶复合物的核心成分)在癌症及癌症治疗中的多方面作用
Biomolecules. 2025 Jun 22;15(7):912. doi: 10.3390/biom15070912.
2
N6-methyladenosine RNA modification regulates the transcription of SLC7A11 through KDM6B and GATA3 to modulate ferroptosis.N6-甲基腺苷RNA修饰通过KDM6B和GATA3调节SLC7A11的转录以调控铁死亡。
J Biomed Sci. 2025 Jan 13;32(1):8. doi: 10.1186/s12929-024-01100-y.
3
N6-Methyladenosine Methyltransferase Component KIAA1429 Is a Potential Target of Cancer Therapy.

本文引用的文献

1
Crosstalk between 5-methylcytosine and N-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma.5-甲基胞嘧啶与 N6-甲基腺苷调控机制在肝癌的疾病进展、治疗反应及药物基因组学特征中的作用
Mol Cancer. 2023 Jan 10;22(1):5. doi: 10.1186/s12943-022-01706-6.
2
Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma.定义一个新的铜死亡相关 lncRNA 特征,用于揭示肺腺癌中不同的生存、基因组改变和治疗意义。
J Immunol Res. 2022 Oct 14;2022:2756611. doi: 10.1155/2022/2756611. eCollection 2022.
3
N6-甲基腺苷甲基转移酶组件 KIAA1429 是癌症治疗的潜在靶点。
Biomolecules. 2024 Oct 17;14(10):1319. doi: 10.3390/biom14101319.
4
KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an mA-YTHDF2-dependent manner.KIAA1429 通过依赖于 mA-YTHDF2 的方式来破坏 RASD1 mRNA 的稳定性,从而促进胃癌的进展。
J Transl Med. 2024 Jun 20;22(1):584. doi: 10.1186/s12967-024-05375-5.
5
Correlation between RNA N6-methyladenosine and ferroptosis in cancer: current status and prospects.癌症中RNA N6-甲基腺嘌呤与铁死亡的相关性:现状与展望
Front Cell Dev Biol. 2024 Mar 13;12:1252064. doi: 10.3389/fcell.2024.1252064. eCollection 2024.
Targeting ferroptosis as a vulnerability in cancer.
针对癌症中的铁死亡脆弱性。
Nat Rev Cancer. 2022 Jul;22(7):381-396. doi: 10.1038/s41568-022-00459-0. Epub 2022 Mar 25.
4
Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.肿瘤微环境中的铁死亡、坏死性凋亡和细胞焦亡:小细胞肺癌免疫治疗的新视角。
Semin Cancer Biol. 2022 Nov;86(Pt 3):273-285. doi: 10.1016/j.semcancer.2022.03.009. Epub 2022 Mar 12.
5
Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis.非酒精性脂肪性肝病相关肝细胞癌的临床特征、监测、治疗分配和结局:系统评价和荟萃分析。
Lancet Oncol. 2022 Apr;23(4):521-530. doi: 10.1016/S1470-2045(22)00078-X. Epub 2022 Mar 4.
6
Emerging immunotherapy for HCC: A guide for hepatologists.肝癌的新兴免疫疗法:肝脏病学家指南。
Hepatology. 2022 Jun;75(6):1604-1626. doi: 10.1002/hep.32447. Epub 2022 Apr 7.
7
mA methylation is required for dihydroartemisinin to alleviate liver fibrosis by inducing ferroptosis in hepatic stellate cells.二氢青蒿素通过诱导肝星状细胞发生铁死亡来减轻肝纤维化,这需要 mA 甲基化。
Free Radic Biol Med. 2022 Mar;182:246-259. doi: 10.1016/j.freeradbiomed.2022.02.028. Epub 2022 Mar 4.
8
AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma.AGA 临床实践指南:肝细胞癌的系统治疗。
Gastroenterology. 2022 Mar;162(3):920-934. doi: 10.1053/j.gastro.2021.12.276.
9
Characterization of Interplay Between Autophagy and Ferroptosis and Their Synergistical Roles on Manipulating Immunological Tumor Microenvironment in Squamous Cell Carcinomas.探讨自噬与铁死亡相互作用及其在调控鳞状细胞癌免疫肿瘤微环境中的协同作用。
Front Immunol. 2022 Feb 4;12:739039. doi: 10.3389/fimmu.2021.739039. eCollection 2021.
10
COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma.COMMD10 通过破坏肝癌中的铜铁平衡抑制 HIF1α/CP 循环来增强铁死亡和放射敏感性。
J Hepatol. 2022 May;76(5):1138-1150. doi: 10.1016/j.jhep.2022.01.009. Epub 2022 Jan 29.